Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2558-63. doi: 10.1128/AAC.02794-15. Print 2016 Apr.

Abstract

We evaluated the antimicrobial susceptibility of 1,454 organisms consecutively collected from patients with bacteremia associated with skin and skin structure infections. The most common organisms obtained wereStaphylococcus aureus(670 organisms [46.1%]),Escherichia coli(200 organisms [13.8%]), β-hemolytic streptococci (βHS) (138 organisms [9.5%]), andKlebsiella pneumoniae(109 organisms [7.5%]). The susceptibility rates for ceftaroline were 97.9% forS. aureus(95.9% among methicillin-resistantS. aureus[MRSA]), 100.0% for βHS, 86.5% forE. coli, and 89.0% forK. pneumoniae Ceftaroline and tigecycline provided the best overall coverage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academic Medical Centers
  • Anti-Bacterial Agents / pharmacology*
  • Ceftaroline
  • Cephalosporins / pharmacology*
  • Community-Acquired Infections
  • Escherichia coli / drug effects*
  • Escherichia coli / growth & development
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / epidemiology
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / growth & development
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives
  • Minocycline / pharmacology
  • Skin / drug effects
  • Skin / microbiology
  • Staphylococcal Skin Infections / drug therapy
  • Staphylococcal Skin Infections / epidemiology
  • Staphylococcal Skin Infections / microbiology
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / microbiology
  • Streptococcus / drug effects*
  • Streptococcus / growth & development
  • Tigecycline
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Minocycline
  • Tigecycline
  • Ceftaroline